When biotech company Integral Molecular set up shop in University City two decades ago, the team already had viruses on the brain.

CEO Ben Doranz had been researching the HIV virus in the late 1990s at the University of Pennsylvania, and in 2001, cofounded the company at the University City Science Center incubator with some of his colleagues. Integral Molecular has since expanded to multiple spaces within the Science Center, focusing on research and development of therapeutic antibodies.

“Our core business is research, not clinical,” Doranz said. “We’re not developing vaccines, or drugs, but we will develop the tech behind drugs and vaccines.”

READ FULL ARTICLE HERE